Skip to content
Abivax
EN
FR
About Abivax
Our Mission
Company History
Our Leadership
Contact Us
Our Science
Novel MOA
Obefazimod
Our Research
Our Pipeline
Publications
Investors
Overview
Press Releases
News
Share Price
Investor Documents
General Meeting
Corporate Presentation
EN
FR
New Therapeutic Targets